Paloma Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,802
| Closed | -$207K | – | 904 |
|
|
2022
Q1 | $207K | Buy |
+3,802
| New | +$207K | 0.01% | 1046 |
|
|
2020
Q1 | – | Sell |
-4,479
| Closed | -$263K | – | 1371 |
|
|
2019
Q4 | $263K | Sell |
4,479
-12,981
| -74% | -$762K | ﹤0.01% | 1543 |
|
|
2019
Q3 | $931K | Buy |
+17,460
| New | +$931K | 0.02% | 587 |
|
|
2019
Q2 | – | Sell |
-13,256
| Closed | -$692K | – | 1609 |
|
|
2019
Q1 | $692K | Buy |
+13,256
| New | +$692K | 0.02% | 643 |
|
|
2017
Q2 | – | Sell |
-10,402
| Closed | -$549K | – | 1726 |
|
|
2017
Q1 | $549K | Buy |
10,402
+2,482
| +31% | +$131K | 0.01% | 1093 |
|
|
2016
Q4 | $381K | Buy |
+7,920
| New | +$381K | ﹤0.01% | 1184 |
|
|
2016
Q3 | – | Sell |
-7,938
| Closed | -$430K | – | 1468 |
|
|
2016
Q2 | $430K | Buy |
+7,938
| New | +$430K | ﹤0.01% | 1173 |
|